Australia's most trusted
source of pharma news
Thursday, 02 May 2024
Posted 15 April 2024 PM
GSK has landed a multi-drug funding deal with New Zealand's Pharmac, securing reimbursement for new drugs by offering price drops across a range of its products.
The deal will see three new drugs funded from 1 May, with two others winning population expansions. For three other GSK products already available in New Zealand, there will be no change except the company will offer a rebate, effectively lowering the cost.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.